US EditionDiabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs
The bill would also create a 10-state pilot to expand affordable insulin for uninsured Americans, as manufacturers and insurers face pressure over access.
- Senators Jeanne Shaheen, Raphael Warnock, Susan Collins, and John Kennedy introduced the INSULIN Act last week, capping out-of-pocket insulin at $35 monthly for privately insured Americans and launching a pilot program for uninsured residents in 10 states.
- Roughly 8.1 million Americans use insulin to manage diabetes, yet many face steep costs despite state-level caps. Previous federal efforts to mandate a $35 monthly limit for private plans failed in the Senate, blocked by political opposition.
- Marlee Brandon paid $194 last week for her son Bain Brandon's one-month insulin supply and backup pens. Patient Breana Glover called the proposed cap a "small step towards everything becoming even more accessible."
- PhRMA spokesperson Chanse Jones stated, "We look forward to working with policymakers to ensure middlemen don't stand between patients and their medicines." Manufacturers Sanofi and Novo Nordisk committed to expanding affordability programs.
- Matthew Fiedler of the Brookings Institution warns that about 57% of private plans are self-insured and exempt from state regulations, potentially limiting the bill's reach. Competing congressional priorities pose additional hurdles to passage.
74 Articles
74 Articles
Diabetes advocates hold out hope as a bipartisan bill revives efforts to lower insulin costs
A bipartisan group of senators is aiming to relieve high insulin costs with the INSULIN Act, a bill to cap the cost of the lifesaving drug at $35 per month for Americans with private insurance plans.
Helena Independent Record
Diabetes advocates hopeful as a bipartisan bill revives efforts to lower insulin costs
The legislation is the latest in a long effort to rein in insulin prices for a wider population after Congress did so for Medicare beneficiaries in 2022.
Associated Press News
Diabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs
A bipartisan group of senators is aiming to relieve high insulin costs for more Americans. A new bill introduced last week would cap the cost of the lifesaving drug at $35 per month for people with private insurance plans, and launch a pilot program to provide more affordable insulin to uninsured Am
Telemundo Area de la Bahía 48
Bain Brandon, two years old, has type 1 diabetes and needs insulin to live. But even with health insurance, the price is not low. A one-month supply of insulin bottles and a three-month supply of backup pens for the Mississippi child cost his parents $194 last week, said his 29-year-old mother, Marlee Brandon. They can pay for it now, but she is worried about the future. “One day, Bain will be an adult and will no longer be able to be covered by…
Bill Approves Diabetes Screening
OKLAHOMA CITY – Sen. Carri Hicks has won bipartisan approval from the full Senate for Senate Bill 1427, to ensure parents will have access to Type 1 diabetes (T1D) screening for their children if they choose. Oklahoma consistently ranks among the worst in the nation for diabetes prevalence, and has one of the highest death rates.
Coverage Details
Bias Distribution
- 68% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
